Genpact, BMG3922B1072

Argus raises target to USD 39.00 for Genpact stock

Published on 10/20/2026 at 20:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Genpact reported USD 1.34 billion revenue in Q2 2026, up 7.10 percent year over year. Genpact stock costs EUR 34.29 on October 20, 2026, up 1.63 percent versus the Xetra close.

Analyst target and reporting date

  • Argus raised its Genpact target to USD 39.00 on October 14, 2026.
  • Genpact reported Q2 2026 revenue of USD 1.34 billion, up 7.10 percent year over year.
  • Genpact stock costs EUR 34.29 at Lang & Schwarz on October 20, 2026 at 8:33 p.m. CEST, 1.63 percent above the Xetra close of October 19, 2026.
  • Genpact is expected to report third-quarter results on November 5, 2026.
Genpact, BMG3922B1072, Illustration mit AI erstellt.

Genpact Limited stock (ISIN BMG3922B1072) is trading at EUR 34.29 at Lang & Schwarz on October 20, 2026 at 8:33 p.m. CEST, up 1.63 percent versus the Xetra close of October 19, 2026. Argus raised its target price for Genpact to USD 39.00 in a note dated October 14, 2026, according to Yahoo Finance.

Target leaves limited upside

Genpact's current NYSE price was USD 38.53 at 2:35 p.m. ET on October 20, 2026. The Argus target of USD 39.00 therefore stands 1.22 percent above that price, using the same home-exchange currency.

The latest quarterly figures provide the operating context. Genpact reported USD 1.343 billion of revenue in the second quarter of 2026, an increase of 7.10 percent from the same quarter a year earlier, while Advanced Technology Solutions revenue grew 24.10 percent to USD 363.00 million, according to Benzinga.

How does the price compare?

Genpact's USD 38.53 price sits within a 52-week range of USD 26.85 to USD 48.64 as of October 20, 2026. The stock is 20.81 percent below its 52-week high and 43.50 percent above its 52-week low. Trading volume was 558,281 shares, while the market capitalization stood at USD 6.5 billion.

Results date is November 5

Genpact is expected to announce third-quarter 2026 results on November 5, 2026, after the market closes, with a conference call scheduled for 5:00 p.m. ET, according to MarketBeat. The same preview calls for third-quarter revenue of USD 1.38 billion and earnings per share of USD 1.04, compared with USD 1.29 billion and USD 0.97 in the year-earlier quarter.

For investors, the next test is whether the faster-growing technology business can sustain its contribution while the company shifts away from lower-priority work. The second-quarter adjusted operating income margin was 17.40 percent, and adjusted diluted earnings per share reached USD 1.00.

NYSE quote remains below yearly high

At Lang & Schwarz, Genpact stock stood at EUR 34.29 on October 20, 2026 at 8:33 p.m. CEST, 1.63 percent above the Xetra close of October 19, 2026 at EUR 33.74. The NYSE price was USD 38.53 at 2:35 p.m. ET on October 20, 2026.

The further course of trading is shown by the continuously updated real-time quote of Genpact stock.

Genpact stock key figures

  • Company: Genpact Limited
  • ISIN: BMG3922B1072
  • Ticker: G
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 20, 2026, 8:33 p.m. CEST): EUR 34.29
  • Change versus Xetra close: plus 1.63 percent
  • Xetra close (October 19, 2026): EUR 33.74
  • Market capitalization: USD 6.5 billion (as of October 20, 2026)
  • 52-week range: USD 26.85-48.64 (as of October 20, 2026)
  • Sector / Industry: Technology / Information Technology Services
  • Next earnings date: November 5, 2026

Market context: Market report S&P 500.

More news and analyses on Genpact stock

Disclaimer...
en | BMG3922B1072 | GENPACT | boerse | 70377432 | bgmi